SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Bacil Pharma Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
524516 INE711D01018 17.9843935 Not Listed 0 52.96 47.92 0.77 10
Quarters :
ParticularsJun 2025(Rs.Cr)Mar 2025(Rs.Cr)Dec 2024(Rs.Cr)
Gross Sales0.000.000.00
Other Operating Income0.000.000.00
Other Income 1.000.090.00
Total Income1.000.090.00
Total Expenditure 0.110.070.06
PBIDT0.890.02-0.06
Interest 0.000.000.00
PBDT0.890.02-0.06
Depreciation0.000.000.00
Tax0.220.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax0.000.000.00
Reported Profit After Tax0.670.02-0.06
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item0.670.02-0.06
    
EPS (Unit Curr.)0.480.03-0.10
EPS (Adj) (Unit Curr.)0.480.03-0.10
Calculated EPS (Unit Curr.)1.140.03-0.10
Calculated EPS (Adj) (Unit Curr.)1.140.03-0.10
Calculated EPS (Ann.) (Unit Curr.)4.540.11-0.42
Calculated EPS (Adj) (Ann.) (Unit Curr.)4.540.11-0.42
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity5.895.895.89
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)0.000.000.00
PBDTM(%)0.000.000.00
PATM(%)0.000.000.00